A detailed history of National Bank Of Canada transactions in Johnson & Johnson stock. As of the latest transaction made, National Bank Of Canada holds 2,336,368 shares of JNJ stock, worth $349 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
2,336,368
Previous 2,336,368 -0.0%
Holding current value
$349 Million
Previous $379 Million -0.0%
% of portfolio
0.52%
Previous 0.52%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$145.48 - $167.38 $135 Million - $156 Million
-930,720 Reduced 28.49%
2,336,368 $379 Million
Q2 2024

Aug 02, 2024

BUY
$144.38 - $157.78 $118 Million - $129 Million
817,081 Added 33.35%
3,267,088 $478 Million
Q1 2024

May 13, 2024

BUY
$155.22 - $162.74 $174 Million - $183 Million
1,122,963 Added 84.62%
2,450,007 $388 Million
Q4 2023

Feb 06, 2024

SELL
$145.6 - $158.88 $74.2 Million - $81 Million
-509,560 Reduced 27.74%
1,327,044 $208 Million
Q3 2023

Oct 10, 2023

SELL
$155.75 - $174.48 $80.9 Million - $90.7 Million
-519,611 Reduced 22.05%
1,836,604 $286 Million
Q2 2023

Jul 26, 2023

BUY
$154.35 - $166.11 $218 Million - $234 Million
1,411,656 Added 149.45%
2,356,215 $390 Million
Q1 2023

Apr 12, 2023

SELL
$151.05 - $180.26 $56.3 Million - $67.2 Million
-372,675 Reduced 28.29%
944,559 $146 Million
Q4 2022

Jan 24, 2023

BUY
$160.2 - $179.79 $44.2 Million - $49.6 Million
275,715 Added 26.47%
1,317,234 $0
Q3 2022

Oct 13, 2022

BUY
$161.33 - $179.52 $27.9 Million - $31.1 Million
173,013 Added 19.92%
1,041,519 $172 Million
Q2 2022

Jul 28, 2022

SELL
$168.19 - $186.01 $53.6 Million - $59.3 Million
-318,571 Reduced 26.84%
868,506 $157 Million
Q1 2022

May 05, 2022

SELL
$158.14 - $179.59 $77 Million - $87.5 Million
-486,944 Reduced 29.09%
1,187,077 $215 Million
Q4 2021

Jan 24, 2022

BUY
$155.93 - $173.01 $261 Million - $290 Million
1,674,021 New
1,674,021 $286 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $390B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.